Detalhe da pesquisa
1.
Publisher Correction: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
Nature
; 572(7768): E10, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337923
2.
Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
Nature
; 570(7762): 528-532, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168092
3.
Mycobacterium tuberculosis infection drives differential responses in the bone marrow hematopoietic stem and progenitor cells.
Infect Immun
; 91(10): e0020123, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37754680
4.
Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons.
mBio
; 14(5): e0094623, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682004
5.
High-throughput phenogenotyping of Mycobacteria tuberculosis clinical strains reveals bacterial determinants of treatment outcomes.
bioRxiv
; 2023 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090677
6.
Immunometabolism during Mycobacterium tuberculosis Infection.
Trends Microbiol
; 28(10): 832-850, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409147
7.
Publisher Correction: Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
Nat Microbiol
; 3(11): 1327, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30327492
8.
Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes.
Nat Microbiol
; 3(10): 1099-1108, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224802